The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring repre...
Gespeichert in:
| Veröffentlicht in: | Clinical radiology 2014-03, Vol.69 (3), p.221-230 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 230 |
|---|---|
| container_issue | 3 |
| container_start_page | 221 |
| container_title | Clinical radiology |
| container_volume | 69 |
| creator | Hoey, E.T.D Teoh, J.K Das, I Ganeshan, A Simpson, H Watkin, R.W |
| description | Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring represent an unstable electrophysiological substrate that creates susceptibility to malignant ventricular arrhythmias. Cardiovascular magnetic resonance imaging (CMR) is widely used for the diagnosis of HCM, especially in patients with an incomplete or inconclusive echocardiography study. CMR can provide precise non-invasive assessment of biventricular function, wall thickness, and assessment of myocardial fibrosis, using inversion recovery gadolinium-enhanced sequences. CMR is also one of the most promising avenues of research in HCM, and in recent years, has provided many new insights and identified a number of potential adverse prognostic indicators for SD. Future work is still needed to integrate CMR findings into traditional risk assessment algorithms. This paper reviews the evolving role of CMR for risk stratification in HCM including assessment of myocardial hypertrophy, fibrosis and ischaemia. |
| doi_str_mv | 10.1016/j.crad.2013.11.012 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1493801535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926013005436</els_id><sourcerecordid>1493801535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-7f1eaaf0ed1cae15709cb44cf32e1b491829763076b7a07858cd8a7138975593</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVpaTZpv0APRcde7Gr0x7agFEpok0BKIN1DTxVaeZzVxrZcyQ7428dmtz300MsMA-89mN8j5B2wHBgUHw-5i7bOOQORA-QM-AuyAVGojHP98yXZMMZ0pnnBzsh5Sof1lFy-JmdcSuBCqQ35td0jxQ7jg-8faAwt0tBQZ2Ptw5NNbmptpN_vb2gTIo0-PdI0Rjv6xrtlhp76nu7nAeMYw7D37mTt5jDYcT-_Ia8a2yZ8e9oXZPvt6_byOru9u7q5_HKbOanUmJUNoLUNwxqcRVAl024npWsER9hJDRXXZSFYWexKy8pKVa6ubAmi0qVSWlyQD8fYIYbfE6bRdD45bFvbY5iSAalFxUAJtUj5UepiSCliY4boOxtnA8ysWM3BrFjNitUAmAXrYnp_yp92HdZ_LX84LoJPRwEuTz55jCY5j73D2kd0o6mD_3_-53_srvX9grh9xBnTIUyxX_AZMIkbZn6sTa69gmBMSVGIZ-zink8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1493801535</pqid></control><display><type>article</type><title>The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Hoey, E.T.D ; Teoh, J.K ; Das, I ; Ganeshan, A ; Simpson, H ; Watkin, R.W</creator><creatorcontrib>Hoey, E.T.D ; Teoh, J.K ; Das, I ; Ganeshan, A ; Simpson, H ; Watkin, R.W</creatorcontrib><description>Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring represent an unstable electrophysiological substrate that creates susceptibility to malignant ventricular arrhythmias. Cardiovascular magnetic resonance imaging (CMR) is widely used for the diagnosis of HCM, especially in patients with an incomplete or inconclusive echocardiography study. CMR can provide precise non-invasive assessment of biventricular function, wall thickness, and assessment of myocardial fibrosis, using inversion recovery gadolinium-enhanced sequences. CMR is also one of the most promising avenues of research in HCM, and in recent years, has provided many new insights and identified a number of potential adverse prognostic indicators for SD. Future work is still needed to integrate CMR findings into traditional risk assessment algorithms. This paper reviews the evolving role of CMR for risk stratification in HCM including assessment of myocardial hypertrophy, fibrosis and ischaemia.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2013.11.012</identifier><identifier>PMID: 24412355</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cardiomyopathy, Hypertrophic - diagnosis ; Contrast Media ; Fibrosis ; Humans ; Magnetic Resonance Imaging ; Myocardial Ischemia - diagnosis ; Radiology ; Risk Assessment - methods</subject><ispartof>Clinical radiology, 2014-03, Vol.69 (3), p.221-230</ispartof><rights>The Royal College of Radiologists</rights><rights>2013 The Royal College of Radiologists</rights><rights>Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-7f1eaaf0ed1cae15709cb44cf32e1b491829763076b7a07858cd8a7138975593</citedby><cites>FETCH-LOGICAL-c455t-7f1eaaf0ed1cae15709cb44cf32e1b491829763076b7a07858cd8a7138975593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2013.11.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24412355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoey, E.T.D</creatorcontrib><creatorcontrib>Teoh, J.K</creatorcontrib><creatorcontrib>Das, I</creatorcontrib><creatorcontrib>Ganeshan, A</creatorcontrib><creatorcontrib>Simpson, H</creatorcontrib><creatorcontrib>Watkin, R.W</creatorcontrib><title>The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring represent an unstable electrophysiological substrate that creates susceptibility to malignant ventricular arrhythmias. Cardiovascular magnetic resonance imaging (CMR) is widely used for the diagnosis of HCM, especially in patients with an incomplete or inconclusive echocardiography study. CMR can provide precise non-invasive assessment of biventricular function, wall thickness, and assessment of myocardial fibrosis, using inversion recovery gadolinium-enhanced sequences. CMR is also one of the most promising avenues of research in HCM, and in recent years, has provided many new insights and identified a number of potential adverse prognostic indicators for SD. Future work is still needed to integrate CMR findings into traditional risk assessment algorithms. This paper reviews the evolving role of CMR for risk stratification in HCM including assessment of myocardial hypertrophy, fibrosis and ischaemia.</description><subject>Cardiomyopathy, Hypertrophic - diagnosis</subject><subject>Contrast Media</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Myocardial Ischemia - diagnosis</subject><subject>Radiology</subject><subject>Risk Assessment - methods</subject><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVpaTZpv0APRcde7Gr0x7agFEpok0BKIN1DTxVaeZzVxrZcyQ7428dmtz300MsMA-89mN8j5B2wHBgUHw-5i7bOOQORA-QM-AuyAVGojHP98yXZMMZ0pnnBzsh5Sof1lFy-JmdcSuBCqQ35td0jxQ7jg-8faAwt0tBQZ2Ptw5NNbmptpN_vb2gTIo0-PdI0Rjv6xrtlhp76nu7nAeMYw7D37mTt5jDYcT-_Ia8a2yZ8e9oXZPvt6_byOru9u7q5_HKbOanUmJUNoLUNwxqcRVAl024npWsER9hJDRXXZSFYWexKy8pKVa6ubAmi0qVSWlyQD8fYIYbfE6bRdD45bFvbY5iSAalFxUAJtUj5UepiSCliY4boOxtnA8ysWM3BrFjNitUAmAXrYnp_yp92HdZ_LX84LoJPRwEuTz55jCY5j73D2kd0o6mD_3_-53_srvX9grh9xBnTIUyxX_AZMIkbZn6sTa69gmBMSVGIZ-zink8</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Hoey, E.T.D</creator><creator>Teoh, J.K</creator><creator>Das, I</creator><creator>Ganeshan, A</creator><creator>Simpson, H</creator><creator>Watkin, R.W</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy</title><author>Hoey, E.T.D ; Teoh, J.K ; Das, I ; Ganeshan, A ; Simpson, H ; Watkin, R.W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-7f1eaaf0ed1cae15709cb44cf32e1b491829763076b7a07858cd8a7138975593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Cardiomyopathy, Hypertrophic - diagnosis</topic><topic>Contrast Media</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Myocardial Ischemia - diagnosis</topic><topic>Radiology</topic><topic>Risk Assessment - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoey, E.T.D</creatorcontrib><creatorcontrib>Teoh, J.K</creatorcontrib><creatorcontrib>Das, I</creatorcontrib><creatorcontrib>Ganeshan, A</creatorcontrib><creatorcontrib>Simpson, H</creatorcontrib><creatorcontrib>Watkin, R.W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoey, E.T.D</au><au>Teoh, J.K</au><au>Das, I</au><au>Ganeshan, A</au><au>Simpson, H</au><au>Watkin, R.W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>69</volume><issue>3</issue><spage>221</spage><epage>230</epage><pages>221-230</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><abstract>Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring represent an unstable electrophysiological substrate that creates susceptibility to malignant ventricular arrhythmias. Cardiovascular magnetic resonance imaging (CMR) is widely used for the diagnosis of HCM, especially in patients with an incomplete or inconclusive echocardiography study. CMR can provide precise non-invasive assessment of biventricular function, wall thickness, and assessment of myocardial fibrosis, using inversion recovery gadolinium-enhanced sequences. CMR is also one of the most promising avenues of research in HCM, and in recent years, has provided many new insights and identified a number of potential adverse prognostic indicators for SD. Future work is still needed to integrate CMR findings into traditional risk assessment algorithms. This paper reviews the evolving role of CMR for risk stratification in HCM including assessment of myocardial hypertrophy, fibrosis and ischaemia.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24412355</pmid><doi>10.1016/j.crad.2013.11.012</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9260 |
| ispartof | Clinical radiology, 2014-03, Vol.69 (3), p.221-230 |
| issn | 0009-9260 1365-229X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1493801535 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Cardiomyopathy, Hypertrophic - diagnosis Contrast Media Fibrosis Humans Magnetic Resonance Imaging Myocardial Ischemia - diagnosis Radiology Risk Assessment - methods |
| title | The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A44%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20emerging%20role%20of%20cardiovascular%20MRI%20for%20risk%20stratification%20in%20hypertrophic%20cardiomyopathy&rft.jtitle=Clinical%20radiology&rft.au=Hoey,%20E.T.D&rft.date=2014-03-01&rft.volume=69&rft.issue=3&rft.spage=221&rft.epage=230&rft.pages=221-230&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2013.11.012&rft_dat=%3Cproquest_cross%3E1493801535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1493801535&rft_id=info:pmid/24412355&rft_els_id=S0009926013005436&rfr_iscdi=true |